Lisinopril/HCTZ

CHEBI:CHEBI_749027

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
205326
product_type
HUMAN PRESCRIPTION DRUG
route
ORAL
dosage_form
TABLET
marketing_category
ANDA
listing_expiration_date
20241231
active_ingredient_name
LISINOPRIL
active_ingredient_strength
20 mg/1
unii
E7199S1YWR
nui
M0471776
pharm_class_epc
Thiazide Diuretic [EPC]
pharm_class
Angiotensin-converting Enzyme Inhibitors [MoA]
pharm_class_pe
Increased Diuresis [PE]
pharm_class_cs
Thiazides [CS]
labeler_name
Direct_Rx
manufacturer_name
Direct_Rx
marketing_start_date
20190807
package_marketing_start_date
20190807
application_number
ANDA076194
generic_name
Lisinopril/HCTZ
brand_name
Lisinopril/HCTZ
brand_name_base
Lisinopril/HCTZ
product_ndc
61919-523
spl_id
ea4e7175-945f-6be8-e053-2a95a90a507c
package_ndc
61919-523-30
package_description
30 TABLET in 1 BOTTLE (61919-523-30)
spl_set_id
8f8cfb63-073c-c156-e053-2995a90a61e7
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class